Medpace Q3 2026 diluted EPS climbs 25% to $4.84

Bitget2026/10/21 20:21

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Medpace’s third-quarter 2026 GAAP diluted earnings rose 25% year over year to $4.84 per share.
Revenue increased 9% year over year to $716 million.
Net new business awards climbed 11% year over year to $873.4 million.
A new $1 billion stock repurchase authorization runs through December 31, 2028, replacing the previous authorization.
Full-year 2026 GAAP diluted earnings are forecast at $17.97 to $18.32 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261021758492) on October 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Medpace Q3 2026 diluted EPS climbs 25% to $4.84

You may also like

Crypto prices